(Q71944789)

English

Immunohistochemically demonstrated expression of HLA‐DR antigen in colorectal adenocarcinomas and its relation to clinicopathological features

scientific article published on 01 August 1995

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7630170%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Immunohistochemically demonstrated expression of HLA-DR antigen in colorectal adenocarcinomas and its relation to clinicopathological features (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7630170%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Immunohistochemically demonstrated expression of HLA‐DR antigen in colorectal adenocarcinomas and its relation to clinicopathological features (English)

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

1 reference

based on heuristic

inferred from title

author name string

M. Morita

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630170

22 June 2024

K. Tanaka

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630170

22 June 2024

H. Kawanishi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630170

22 June 2024

M. Tsuji

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630170

22 June 2024

T. Ookusa

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630170

22 June 2024

H. Takada

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630170

22 June 2024

A. Okamura

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630170

22 June 2024

K. Hioki

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630170

22 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7630170

22 June 2024

publication date

1 August 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7630170%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjso.2930590407

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.2930590407

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Journal of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7630170%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

59

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7630170%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7630170%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

233-238

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7630170%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx

1

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Expression of HLA-DR and secretory component antigens and lymphocyte infiltration in human gastric nonmalignant and malignant tissues: an immunohistochemical study

2

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Immunocytochemical study of the cellular immune response in meningiomas

3

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon

4

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness

5

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Class II (HLA-DR, -DP, and -DO) antigens on intestinal epithelia in ulcerative colitis, Crohn's disease, colorectal cancer and normal small intestine

7

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Special subtypes of pulmonary adenocarcinomas indicated by different tumor cell HLA-expression and stromal infiltrates. A light, electron microscopic and immunohistologic study

10

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma

13

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

HLA-DR antigen expression in intestinal-type and diffuse-type gastric carcinoma

15

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

An evaluation of the prognostic significance of HLA-DR expression in gastric carcinoma

16

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma

17

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognosis

18

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Expression of HLA ABC and DR antigens in thyroid neoplasia and correlation with mononuclear leukocyte infiltration

19

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma

20

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas

21

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

DNA content and MHC class II antigen expression in malignant melanoma: clinical course

22

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Phenotypic dynamics of tumor progression in human malignant melanoma

24

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes

25

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Enzyme-linked bio-immunoassay for IFN-gamma by HLA-DR induction

26

1 reference

10.1002/JSO.2930590407

https://api.crossref.org/works/10.1002/JSO.2930590407

22 June 2024

Identifiers

10.1002/JSO.2930590407

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7630170%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7630170%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71944789&oldid=2215218992"